Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Enveric Biosciences, Inc. - Common Stock
(NQ:
ENVB
)
1.600
+0.010 (+0.63%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump
February 11, 2022
The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday.
Via
Benzinga
41 Stocks Moving In Friday's Mid-Day Session
February 11, 2022
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations...
Via
Benzinga
Enveric Biosciences Shares Fall After $10M Equity Raise
February 11, 2022
Enveric Biosciences Inc (NASDAQ: ENVB) has priced its previously announced underwritten public offering of 20 million shares and warrants to purchase up to 20 million shares...
Via
Benzinga
23 Stocks Moving in Friday's Pre-Market Session
February 11, 2022
Gainers Modular Medical Inc (NASDAQ: MODD) rose 321% to $15.64 in pre-market trading. Modular Medical, on Thursday, reported pricing of $15 million public offering...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 10, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI)...
Via
Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
February 09, 2022
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,...
Via
Benzinga
Enveric Biosciences Files Provisional Patent For CBD+Celecoxib Conjugate For Osteoarthritis
February 08, 2022
Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates for Osteoarthritis and other pain indications.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 08, 2022
Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 07, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $22....
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 04, 2022
Gainers Quidel (NASDAQ:QDEL) shares incre...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 01, 2022
Gainers Epizyme (NASDAQ:EPZM) shares incr...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 28, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB)...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 27, 2022
Gainers Avidity Biosciences (NASDAQ:RNA) s...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 18, 2022
Gainers DBV Technologies (NASDAQ:DBVT) sh...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
Gainers ContraFect (NASDAQ:CFRX) stock mo...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 06, 2022
Gainers ContraFect (NASDAQ:CFRX) stock in...
Via
Benzinga
Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021!
January 02, 2022
Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the...
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
December 16, 2021
Gainers Eloxx Pharmaceuticals (NASDAQ:
Via
Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
December 16, 2021
Gainers Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO...
Via
Benzinga
Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline
December 12, 2021
The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
December 10, 2021
Texas NORML Director Hired To Oversee State Policy Reform Efforts The National Organization for the Reform of Marijuana Laws (N...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
December 01, 2021
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Enveric Biosciences' CBD-Based Product Reduces Dermatitis Severity In Animal Study
November 18, 2021
Enveric Biosciences (NASDAQ: ENVB) announced data from a preclinical rodent model evaluating EV102, the company's cannabidiol (CBD) based product in...
Via
Benzinga
Earnings Scheduled For November 16, 2021
November 16, 2021
Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million. • Sea (...
Via
Benzinga
EXCLUSIVE: Benzinga Interviews Mind Cure CEO Kelsey Ramsden with Updates on Latest Press Release
November 09, 2021
Image by: iStock The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored conte...
Via
Benzinga
Bringing Mental Health Pharmacology into the 21st Century: How the Marriage of Enveric Biosciences and MagicMed Industries Could Revolutionize the Way We Treat Mental Health
October 05, 2021
Photo by Christina Victoria Craft on Unsplash The world is finally waking up to the importance of mental health. It is becoming more acceptable to talk about mental illness....
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 05, 2021
Gainers Ocugen (NASDAQ:OCGN) shares moved upwards by 11.11% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.4...
Via
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.